Frequently Asked Questions

Uterine fibroids are non-cancerous (benign) growths in or around the uterus and will be found in approximately 70%-80% of women in the United States. Learn more About Fibroids.

Many women with fibroids have no symptoms and require no intervention. However, fibroids can cause symptoms that significantly interfere with daily activities. Women diagnosed with uterine fibroids also have a higher risk of infertility compared to women without fibroids. Learn more at Fibroid Treatments.

The Sonata Treatment is an incisionless treatment option for women with symptomatic uterine fibroids. The technical term for the procedure is Transcervical Fibroid Ablation (TFA). Learn more at Why Sonata?

The Sonata handpiece is inserted by the doctor through the vagina and into the uterus. Radiofrequency energy is delivered to the fibroid, causing it to shrink over time and relieve symptoms. Learn more at How Sonata Works.

The procedure typically takes less than one hour, depending on the number and size of fibroids treated.

Most patients see improvement in heavy menstrual bleeding within 3 months.

The Sonata Treatment is an outpatient procedure in the United States. The Sonata Treatment can be performed at an outpatient surgical facility or in-office procedure room. Patients are scheduled to return home the same day.

Your doctor will ensure that you are comfortable during the procedure. General anesthesia is typically not required but is an option along with conscious sedation and regional anesthesia (epidural or spinal anesthesia). Your doctor will discuss anesthesia options and determine what is best for you.

The Sonata Treatment has been clinically proven to be safe and effective in women with symptomatic uterine fibroids.

There are risks associated with any medical procedure. Your doctor should discuss all potential risks in detail. For complete safety information, see Safety Information.

Common side effects include bleeding, spotting, cramping, post-ablation inflammatory symptoms, and/or discharge. Your doctor should discuss all potential risks in detail. For complete safety information, see Safety Information.

Most insurance plans require pre-authorization for the Sonata Treatment. Our Sonata Authorization Support Team will work directly with your insurance company to educate and advocate on your behalf. If your doctor recommends the Sonata Treatment and you have specific questions about your health plan, you can contact us at (877) 590-0389.

The Sonata Treatment is an appropriate option for many women with symptomatic uterine fibroids. You may be a candidate if your period:

• lasts longer than 7 days, and/or is heavy
• affects your work and daily activities

The Sonata Treatment is not appropriate for women who have:

• current pregnancy
• intratubal implant
• active pelvic infection
• suspected gynecologic cancer

The safety and effectiveness of the Sonata Treatment in women who wish to get pregnant has not been determined. Potential risks or benefits regarding pregnancy are unknown but patients have reported getting pregnant post-treatment. Talk to your doctor about any fertility questions regarding the Sonata Treatment.

The Sonata System is an innovative medical device that received FDA clearance in 2018 for use in the United States and CE mark for use and sale in Europe since 2014.

The Sonata System was developed and is manufactured by Gynesonics, a women’s health company, headquartered in California. Visit the website.